+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Helicobacter Pylori Non-invasive Testing Market Research Report by Test Type, Test Method, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 230 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 4904519
UP TO OFF until Dec 31st 2022
The Global Helicobacter Pylori Non-invasive Testing Market size was estimated at USD 959.83 million in 2021, USD 1,011.46 million in 2022, and is projected to grow at a CAGR of 5.56% to reach USD 1,328.04 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Helicobacter Pylori Non-invasive Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Test Type, the market was studied across Breath Test, Serology Test, and Stool Antigen Test.
  • Based on Test Method, the market was studied across Laboratory-Based Tests, Point-of-care Tests, and Rapid Test Kit.
  • Based on End-User, the market was studied across Clinics and Hospitals.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Helicobacter Pylori Non-invasive Testing market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Helicobacter Pylori Non-invasive Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Helicobacter Pylori Non-invasive Testing Market, including Abbott Laboratories, Alere Inc., Bio-Rad Laboratories, Inc., Biomerica, Inc., Certest Biotec SL, CorisBioconcept SPRL, DiaSorin S.P.A., Exalenz Bioscience Ltd, Medline Industries, Inc., Meridian Bioscience Inc., Quidel Corporation, Sekisui Diagnostics, LLC, Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd., Siemens Healthcare Private Limited, and Thermo Fisher Scientific, Inc.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Helicobacter Pylori Non-invasive Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Helicobacter Pylori Non-invasive Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Helicobacter Pylori Non-invasive Testing Market?
4. What is the competitive strategic window for opportunities in the Global Helicobacter Pylori Non-invasive Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Helicobacter Pylori Non-invasive Testing Market?
6. What is the market share of the leading vendors in the Global Helicobacter Pylori Non-invasive Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Helicobacter Pylori Non-invasive Testing Market?
Frequently Asked Questions about the Global Helicobacter Pylori Non-invasive Testing Market

What is the estimated value of the Global Helicobacter Pylori Non-invasive Testing Market?

The Global Helicobacter Pylori Non-invasive Testing Market was estimated to be valued at $959.83 Million in 2021.

What is the growth rate of the Global Helicobacter Pylori Non-invasive Testing Market?

The growth rate of the Global Helicobacter Pylori Non-invasive Testing Market is 5.5%, with an estimated value of $1328.04 Million by 2027.

What is the forecasted size of the Global Helicobacter Pylori Non-invasive Testing Market?

The Global Helicobacter Pylori Non-invasive Testing Market is estimated to be worth $1328.04 Million by 2027.

Who are the key companies in the Global Helicobacter Pylori Non-invasive Testing Market?

Key companies in the Global Helicobacter Pylori Non-invasive Testing Market include Abbott Laboratories, Alere Inc., Bio, Rad Laboratories, Inc., Biomerica, Inc., Certest Biotec SL, CorisBioconcept SPRL, DiaSorin S.P.A. and Medline Industries, Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of Helicobacter pylori bacterial infection
5.1.1.2. Rising prevalence of gastric ulcer
5.1.1.3. Increasing awareness regarding infection by the government for proper diagnosis
5.1.2. Restraints
5.1.2.1. Low diagnosis rates even in high prevalence geographies
5.1.3. Opportunities
5.1.3.1. Availability of new and advanced non-invasive tests such as real-time PCR and Chemiluminescence Immunoassay (CLIA)
5.1.3.2. Growing demand for point of care testing devices
5.1.4. Challenges
5.1.4.1. Asymptomatic nature of the infection, and stringent regulatory norms
5.2. Cumulative Impact of COVID-19
6. Helicobacter Pylori Non-invasive Testing Market, by Test Type
6.1. Introduction
6.2. Breath Test
6.3. Serology Test
6.4. Stool Antigen Test
7. Helicobacter Pylori Non-invasive Testing Market, by Test Method
7.1. Introduction
7.2. Laboratory-Based Tests
7.3. Point-of-care Tests
7.4. Rapid Test Kit
8. Helicobacter Pylori Non-invasive Testing Market, by End-User
8.1. Introduction
8.2. Clinics
8.3. Hospitals
9. Americas Helicobacter Pylori Non-invasive Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Helicobacter Pylori Non-invasive Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Helicobacter Pylori Non-invasive Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Alere Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Bio-Rad Laboratories, Inc.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Biomerica, Inc.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Certest Biotec SL
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. CorisBioconcept SPRL
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. DiaSorin S.P.A.
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Exalenz Bioscience Ltd
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Medline Industries, Inc.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Meridian Bioscience Inc.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Quidel Corporation
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Sekisui Diagnostics, LLC
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Siemens Healthcare Private Limited
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Thermo Fisher Scientific, Inc
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET DYNAMICS
FIGURE 11. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY TEST TYPE, 2027
FIGURE 14. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY BREATH TEST, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2021 VS 2027 (%)
FIGURE 18. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY TEST METHOD, 2027
FIGURE 20. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY LABORATORY-BASED TESTS, 2018-2027 (USD MILLION)
FIGURE 21. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY POINT-OF-CARE TESTS, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY RAPID TEST KIT, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 24. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2027
FIGURE 26. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 28. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 29. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 30. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 31. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 32. ARGENTINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 33. BRAZIL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. CANADA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. MEXICO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 38. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 39. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 40. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 42. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 43. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 44. AUSTRALIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. INDIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. INDONESIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. JAPAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. MALAYSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. PHILIPPINES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. SINGAPORE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. SOUTH KOREA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. TAIWAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. THAILAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. VIETNAM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 60. DENMARK HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. EGYPT HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. FINLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. FRANCE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. GERMANY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. ISRAEL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. ITALY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. NETHERLANDS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. NIGERIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. NORWAY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. POLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. QATAR HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. RUSSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. SAUDI ARABIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. SOUTH AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. SPAIN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. SWEDEN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. SWITZERLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. TURKEY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. UNITED ARAB EMIRATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. UNITED KINGDOM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 82. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 83. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY BREATH TEST, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY BREATH TEST, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY BREATH TEST, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY SEROLOGY TEST, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STOOL ANTIGEN TEST, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY LABORATORY-BASED TESTS, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY LABORATORY-BASED TESTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY LABORATORY-BASED TESTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY POINT-OF-CARE TESTS, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY POINT-OF-CARE TESTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY POINT-OF-CARE TESTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY RAPID TEST KIT, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY RAPID TEST KIT, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY RAPID TEST KIT, BY REGION, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
TABLE 32. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
TABLE 33. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 34. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 35. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 36. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 37. AMERICAS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 38. ARGENTINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. ARGENTINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 40. ARGENTINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 41. ARGENTINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 42. BRAZIL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. BRAZIL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 44. BRAZIL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 45. BRAZIL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 46. CANADA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 47. CANADA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 48. CANADA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 49. CANADA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 50. MEXICO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 51. MEXICO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 52. MEXICO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 53. MEXICO HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 54. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 55. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 56. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 57. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 58. UNITED STATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 59. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 60. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 61. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 62. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 63. ASIA-PACIFIC HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 64. AUSTRALIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 65. AUSTRALIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 66. AUSTRALIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 67. AUSTRALIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 68. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 69. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 70. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 71. CHINA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 72. INDIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 73. INDIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 74. INDIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 75. INDIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 76. INDONESIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 77. INDONESIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 78. INDONESIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 79. INDONESIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 80. JAPAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 81. JAPAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 82. JAPAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 83. JAPAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 84. MALAYSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 85. MALAYSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 86. MALAYSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 87. MALAYSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 88. PHILIPPINES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 89. PHILIPPINES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 90. PHILIPPINES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 91. PHILIPPINES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 92. SINGAPORE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 93. SINGAPORE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 94. SINGAPORE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 95. SINGAPORE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 96. SOUTH KOREA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 97. SOUTH KOREA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 98. SOUTH KOREA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 99. SOUTH KOREA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 100. TAIWAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 101. TAIWAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 102. TAIWAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 103. TAIWAN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 104. THAILAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 105. THAILAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 106. THAILAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 107. THAILAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 108. VIETNAM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 109. VIETNAM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 110. VIETNAM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 111. VIETNAM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 117. DENMARK HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 118. DENMARK HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 119. DENMARK HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 120. DENMARK HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 121. EGYPT HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 122. EGYPT HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 123. EGYPT HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 124. EGYPT HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 125. FINLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 126. FINLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 127. FINLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 128. FINLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 129. FRANCE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 130. FRANCE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 131. FRANCE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 132. FRANCE HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 133. GERMANY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 134. GERMANY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 135. GERMANY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 136. GERMANY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 137. ISRAEL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 138. ISRAEL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 139. ISRAEL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 140. ISRAEL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 141. ITALY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 142. ITALY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 143. ITALY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 144. ITALY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 145. NETHERLANDS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 146. NETHERLANDS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 147. NETHERLANDS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 148. NETHERLANDS HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 149. NIGERIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 150. NIGERIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 151. NIGERIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 152. NIGERIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 153. NORWAY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 154. NORWAY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 155. NORWAY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 156. NORWAY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 157. POLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 158. POLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 159. POLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 160. POLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 161. QATAR HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 162. QATAR HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 163. QATAR HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 164. QATAR HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 165. RUSSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 166. RUSSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 167. RUSSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 168. RUSSIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 169. SAUDI ARABIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 170. SAUDI ARABIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 171. SAUDI ARABIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 172. SAUDI ARABIA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 173. SOUTH AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 174. SOUTH AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 175. SOUTH AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 176. SOUTH AFRICA HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 177. SPAIN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 178. SPAIN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 179. SPAIN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 180. SPAIN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 181. SWEDEN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 182. SWEDEN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 183. SWEDEN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 184. SWEDEN HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 185. SWITZERLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 186. SWITZERLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 187. SWITZERLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 188. SWITZERLAND HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 189. TURKEY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 190. TURKEY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 191. TURKEY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 192. TURKEY HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 197. UNITED KINGDOM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 198. UNITED KINGDOM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 199. UNITED KINGDOM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY TEST METHOD, 2018-2027 (USD MILLION)
TABLE 200. UNITED KINGDOM HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 201. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 202. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 203. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 204. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET RANKING, BY KEY PLAYER, 2021
TABLE 205. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET SHARE, BY KEY PLAYER, 2021
TABLE 206. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET MERGER & ACQUISITION
TABLE 207. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 208. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 209. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET INVESTMENT & FUNDING
TABLE 210. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 211. GLOBAL HELICOBACTER PYLORI NON-INVASIVE TESTING MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Alere Inc.
  • Bio-Rad Laboratories, Inc.
  • Biomerica, Inc.
  • Certest Biotec SL
  • CorisBioconcept SPRL
  • DiaSorin S.P.A.
  • Exalenz Bioscience Ltd
  • Medline Industries, Inc.
  • Meridian Bioscience Inc.
  • Quidel Corporation
  • Sekisui Diagnostics, LLC
  • Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
  • Siemens Healthcare Private Limited
  • Thermo Fisher Scientific, Inc

Methodology

Loading
LOADING...